文献速递重症综合管理与镇静镇痛心脑血管急症

无创脑脊液顺应性监测方法的验证

Validation of a Noninvasive Approach for Cerebrospinal Compliance Monitoring.
PubMed 文献 · Neurocrit Care · 2025-02-07
一句话结论在神经重症患者中,基于脑动脉血容量波形振幅与颅骨微米级变形传感器脉冲振幅的无创参数Bcomp与有创计算的Ci高度一致(Spearman相关0.88),提示可用于无创评估脑脊液顺应性。

本研究纳入71例接受有创颅内压监测的神经重症患者(68%为创伤性脑损伤),用经颅多普勒获取大脑中动脉血流速度计算脑动脉血容量(CaBV)波形振幅,用颅骨微米级变形传感器(B4C)获取颅骨波形(Skw)脉冲振幅,构建无创参数Bcomp,并与基于有创颅内压波形振幅和CaBV振幅计算的颅内顺应性(Ci)进行一致性和相关性分析。结果显示Ci与Bcomp平均差为-0.28,Spearman相关系数为0.88(P<0.001),二者高度一致且线性相关;顺应性差的患者CaBV最大值显著延迟(P<0.001)。作者认为Bcomp与Ci高度一致,这些发现对临床实时无创评估脑脊液顺应性有前景,值得进一步研究。

要点

  • 在71例接受有创颅内压监测的神经重症患者(68%为创伤性脑损伤)中,无创参数Bcomp与有创计算的Ci平均差为-0.28,Spearman相关系数为0.88(P<0.001)。
  • Bcomp由经颅多普勒计算的脑动脉血容量(CaBV)波形振幅与颅骨微米级变形传感器(B4C)测得的颅骨波形(Skw)脉冲振幅构成,无需有创颅内压探头。
  • 顺应性差的患者中,CaBV最大值显著延迟(P<0.001),提示该血管标志物受颅内阻力影响。
  • 作者认为这些发现对临床实时无创评估脑脊液顺应性有前景,并值得进一步研究。

适用人群与场景

  • 接受有创颅内压监测的神经重症患者;样本中68%为创伤性脑损伤。

研究设计与关键结果

  • 研究类型为验证性临床研究,纳入71例接受有创颅内压监测的神经重症患者(68%为创伤性脑损伤),用经颅多普勒和颅骨微米级变形传感器(B4C)同步获取颅内压波形和颅骨波形(Skw)脉冲振幅,并以脑动脉血容量(CaBV)振幅作为容量替代、颅内压和B4C脉冲振幅作为压力替代,计算有创颅内顺应性(Ci)与无创参数Bcomp。
  • Ci与Bcomp的平均差为-0.28,Spearman相关系数为0.88(P<0.001)。
  • 顺应性差的患者中脑动脉血容量(CaBV)最大值显著延迟(P<0.001)。

证据类型、等级与局限

  • 证据类型:临床验证研究(非随机对照试验),样本量71例。
  • 局限:作者指出这些发现值得进一步研究(warrant further research)。

对床旁实践的改变

  • 作者认为,基于CaBV和Skw脉冲振幅的Bcomp与Ci高度一致,这些发现对临床实时无创评估脑脊液顺应性有前景。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Intracranial pressure (ICP) monitoring is a cornerstone of neurointensive care. However, some limitations of invasive techniques for ICP monitoring to acknowledge are the risk for complications and the lack of robust evidence supporting individualized ICP safety thresholds. Cerebrospinal compliance (CSC) may serve as a more reliable indicator of brain health than ICP alone. Previously, intracranial compliance (Ci), was described as a mathematical model from invasive ICP to assess CSC, using ICP waveform amplitudes and cerebral arterial blood volume (CaBV) waveform amplitudes via transcranial Doppler (TCD). This study aimed to compare Ci with a surrogate parameter based on CaBV waveform amplitudes and pulsatile micrometric skull waveforms (Skw) amplitudes. This noninvasive parameter was named Bcomp.

METHODS: Neurocritical patients undergoing ICP monitoring were evaluated using TCD and the skull micrometric deformation sensor (B4C). ICP waveform (from invasive ICP probes) and Skw (from noninvasive B4C) were analyzed to extract pulse amplitudes, whereas TCD provided cerebral blood velocities from the middle cerebral arteries for CaBV calculation. CSC was measured using the volume/pressure relationship, with CaBV amplitude serving as the volume surrogate, and ICP and B4C pulse amplitudes as surrogates for ICP values. Agreement and correlation analysis was calculated between Ci and Bcomp.

RESULTS: Data from 71 patients were analyzed, with 68% of the sample having suffered traumatic brain injury. Maximum CaBV was significantly delayed in patients with poor CSC (p < 0.001). Ci and Bcomp showed strong agreement and linear correlation (mean difference of - 0.28 and Spearman correlation of 0.88, p < 0.001).

CONCLUSIONS: Using CaBV, which reflects changes in arterial blood volume during the cardiac cycle and Skw pulse amplitudes, Bcomp demonstrated high agreement and correlation with Ci, defined as the product of CaBV and ICP pulse amplitude. The observed shift in CaBV among patients with poor CSC suggests that this vascular marker is influenced by intracranial resistance. These findings are promising for the real-time, noninvasive assessment of CSC in clinical settings and warrant further research.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Brasil S, Ben-Hur I, Cardim D, et al. Validation of a Noninvasive Approach for Cerebrospinal Compliance Monitoring. Neurocrit Care. 2025. PMID: 39920544. doi:10.1007/s12028-024-02205-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。